ArticleInternational journal of molecular sciences2025
Comparative Study on Modulation of Synchronized Neuronal Activity by SK Channels and Na/K-ATPase.
Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Axon as a Self-Modifying Computational System: Autonomous Inference, Adaptive Propagation, and AI-Enabled Mechanistic Insight.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Drug-resistant epilepsy remains a therapeutic challenge, requiring new molecular targets beyond conventional antiepileptic drugs. Small-conductance calcium-activated potassium (SK) channels and Na/K-ATPase (NKA) contribute to afterhyperpolarization via distinct mechanisms, offering complementary ways to suppress hyperexcitability. We examined SK activation and NKA modulation in synchronized epileptiform activity in a primary culture of cortical neurons obtained from rat embryos. Epileptiform discharges were induced by magnesium-free solution and assessed by patch-clamp and calcium imaging. The SK2/3 activator CyPPA (10 µM) reduced epileptiform current (EC) amplitude and integral and decreased synchronized calcium transient (CT) frequency but gradually elevated basal calcium. In contrast, ouabain (1 nM), a selective modulator of high-affinity NKA isoforms, attenuated EC amplitude, strongly suppressed CTs, and showed persistent effects after washout, accompanied by asynchronous glial calcium activity. Co-application of CyPPA with ouabain abolished CyPPA-induced calcium elevation while maintaining suppression of neuronal synchrony. The broader SK/IK activator NS309 (10 µM) reduced CT frequency and basal calcium without affecting glia. Thus, SK activation and NKA signaling suppress epileptiform synchronization through distinct yet convergent pathways: SK channels via afterhyperpolarization and NKA via afterhyperpolarization and calcium-dependent signaling. Their combination enhances efficacy and prevents adverse calcium buildup, supporting SK-NKA co-targeting as a strategy against drug-resistant epilepsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.